Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 686.3;Proximal tubular cells: 536.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.8	14.1	23.6	21.6	31.3	16.6	12.0	7.2	11.8	12.2	9.5	30.0	12.3	12.6	15.5	26.6	12.6	0.9	39.3	4.6	12.1	38.6	9.2	8.9	18.5	35.6	14.8	0.1	16.9	21.9	1.5	19.7	6.2	9.9	20.0	18.3	7.7	11.9	33.9	16.3	0.5	19.5	21.4	5.3	5.7	31.0	50.5	46.2	41.3	0.6	33.9	26.9	0.5	16.6	1.1	19.5	9.4	13.1	9.5	10.4	13.1	15.7	7.9	24.2	27.9	32.2	7.4	18.2	9.5	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5	35.7	38.9	45.7	10.9	3.2	5.9	161.7	229.3	29.4	30.7	52.4	3.9	30.0	250.4	111.1	56.2	32.3	191.9	0.0	40.7	49.6	32.6	10.2	44.9	686.3	101.9	1.6	38.5	46.6	63.1	122.0	44.5	46.6	18.6	61.3	59.2	53.2	84.8	76.3	35.0	536.1	27.2	19.4	17.6	27.7	39.6	4.3	22.5	68.2	98.9	4.5
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 481.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		63000	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.7	7.0	5.2	9.5	7.1	8.9	4.6	6.0	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5.0	7.5	5.1	6.5	4.3	3.8	3.5	9.0	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1.0	6.0	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3.0	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6.0	7.4	6.8	0.0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12.0	25.2	13.8	15.7	10.7
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA					"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	6.1	4.8	22.8	8.6	26.6	16.3	9.1	17.1	19.6	9.0	14.0	21.8	9.7	28.1	8.5	12.3	7.5	10.8	12.4	32.4	26.3	9.2	19.5	5.5	10.8	13.4	15.1	20.4	12.3	28.8	9.3	5.7	66.4	21.3	14.8	12.5	9.9	21.8	10.2	19.5	9.3	25.9	8.0	11.1	16.1	26.9	21.6	22.9	11.9	14.9	4.8	12.2	8.7	7.1	7.2	4.4	8.7	6.3	12.6	5.5	2.7	0.0	4.7	1.4	0.0	4.5	1.7	0.1	0.5	2.0	2.0	1.4	4.7	0.6	8.2	0.8	1.9	8.8	2.4	6.9	1.0	0.4	0.0	0.6	14.1	0.1	19.6	4.6	3.3	0.1	2.9	3.5	0.2	0.0	0.0	4.4	20.6	0.7	15.8	0.1	0.5	19.0	5.6	0.1	25.4	7.6	14.9	0.4	29.2	3.0	3.7	3.4	0.1	0.9	1.9	13.1	0.1	9.1	7.5	0.6	0.0	0.0	0.0	0.2	11.0	0.7	0.0	0.2	20.3	5.2	6.3	3.7	8.7	5.5	6.3	4.5	5.2	3.7	4.8	4.4	7.2	3.2	4.9	0.8	12.6	4.1	2.8	3.2	2.7	22.8	26.6	17.1	19.6	26.3	9.2	15.1	20.4	21.3	22.9	11.9	13.7	25.6	6.7	4.6	2.4	60.2	45.9	9.4	9.1	10.4	0.0	211.3	64.6	3.4	72.5	7.1	29.0	23.3	6.7	6.5	11.6	9.5	5.7	5.0	43.5	0.0	0.0	9.2	7.5	14.5	31.9	8.1	6.8	2.8	28.5	14.3	3.0	14.0	30.4	14.0	0.7	19.4	14.4	0.9	1.1	3.8	350.8	23.5	21.3	3.0
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 98.3;Mucus-secreting cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.9	1.6	1.2	1.6	8.5	9.0	12.4	7.1	5.5	2.0	3.5	4.3	6.6	0.0	8.1	3.1	7.7	9.0	2.9	17.9	1.5	0.1	2.8	16.6	0.8	2.0	6.2	1.6	9.1	6.1	3.9	2.9	2.8	2.9	3.1	1.2	10.5	1.3	2.7	1.4	0.5	7.3	0.8	3.6	20.3	4.4	7.8	26.2	6.8	1.2	1.1	5.4	8.7	6.4	6.9	3.4	3.1	3.6	11.7	2.4	3.3	4.3	2.3	11.3	8.2	3.8	6.7	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1	11.9	40.9	3.0	8.5	6.9	6.0	70.4	25.5	5.3	13.6	10.4	5.9	13.6	10.0	16.5	7.2	13.2	98.3	23.3	29.5	8.5	8.9	8.8	9.2	44.8	14.7	7.9	7.5	10.4	17.2	6.0	10.6	13.8	13.5	19.8	80.6	8.8	18.1	60.0	4.2	51.2	3.4	12.9	9.9	11.6	7.3	9.5	17.5	5.0	60.0	8.9
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261205	"Enzymes, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 42.8;Hepatocytes: 47.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 8.3;neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	19.6	18.3	7.4	1.9	8.3	1.0	8.1	2.7	7.7	13.2	2.6	5.5	10.8	1.2	18.2	14.4	2.0	8.3	8.1	10.9	6.4	3.9	24.4	37.1	8.8	1.7	7.4	6.5	16.7	2.6	21.3	11.0	4.1	6.5	7.1	1.6	10.3	20.4	11.4	9.8	2.1	1.9	6.6	5.5	2.8	1.9	4.0	4.1	0.0	9.2	2.9	1.6	3.5	6.3	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	9.4	10.7	0.0	1.5	7.0	1.1	1.2	0.3	0.0	0.1	0.0	3.1	3.3	0.1	0.0	0.0	0.7	0.0	1.7	0.0	0.1	26.5	3.2	0.3	0.0	7.2	0.0	0.3	0.0	9.1	0.2	0.0	0.0	0.0	5.0	0.6	0.0	0.1	3.2	0.0	0.0	0.0	12.3	1.7	0.0	0.0	2.1	0.0	0.0	11.6	0.0	4.8	5.2	0.3	0.0	1.9	1.8	0.2	0.7	0.1	0.1	0.0	2.3	0.0	2.1	8.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	7.4	8.3	2.7	7.7	6.4	3.9	7.4	6.5	6.5	4.1	20.8	42.8	0.0	7.0	0.8	31.6	19.3	15.3	6.7	5.7	12.2	3.9	1.3	5.0	4.0	33.3	1.0	0.0	0.0	2.6	0.6	4.3	4.4	0.0	47.4	0.6	27.0	0.0	3.1	2.4	6.4	22.2	0.4	0.0	0.0	0.0	19.7	0.2	0.0	22.3	26.7	4.5	6.5	5.7	4.2	0.5	0.1	0.5	0.0	0.0	2.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"kidney: 63.2;liver: 63.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 87.7;Proximal tubular cells: 319.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"T-47d: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		7300			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	63.2	63.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.0	1.8	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	319.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087703	"Disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 38.9;tongue: 55.3"	"Cell type enhanced"	"Detected in some"	11	"Horizontal cells: 1.6;Rod photoreceptor cells: 1.1;Suprabasal keratinocytes: 1.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.2;hTCEpi: 3.6;JURKAT: 6.7;OE19: 3.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024002	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	1.1	0.1	0.3	7.7	0.1	0.1	0.1	0.1	0.5	0.1	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.6	38.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	55.3	11.4	0.1	6.2	0.9	0.2	7.0	0.0	0.2	1.1	0.2	1.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	1.0	0.5	0.2	0.2	0.0	0.0	3.2	0.0	0.9	0.2	0.0	0.5	0.0	0.0	3.6	0.2	0.6	0.1	0.0	6.7	0.0	0.0	0.0	0.1	0.3	0.0	0.6	3.8	0.3	2.3	0.0	0.9	0.4	0.0	1.0	1.4	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	2.3	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.0	0.7	0.9	0.3	0.5	0.0	0.3	1.1	1.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.9	0.4	1.6	0.0	0.0	0.0	0.0
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	3.2	0.5	0.9	10.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.2	15.1	0.0	0.0	1.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.8	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.9	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	1.6	0.9	0.0	0.0	0.7
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 649.9"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	85.8	44.1	0.0	1.4	2.6	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.5	0.0	0.0	3.9	4.8	0.0	0.1	0.0	1.0	4.3	5.7	0.2	0.0	17.7	1.0	5.6	17.7	1.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	6.8	3.0	2.4	0.0	0.5	0.0	0.0	0.6	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2	3.0	0.6	13.7	0.5	1.5	0.0	0.7	12.7	0.0	0.0	3.5	0.0	0.0	10.0	0.6	0.5	1.3	0.0	0.0	22.4	0.1	10.2	8.3	0.0	649.9	0.4	0.0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0.0	0.0	0.4	18.4	0.0	77.1	111.5	0.0	0.0	2.8	0.7	0.6	1.4	0.0	0.0	0.0	0.3
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 162.5;Proximal tubular cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.6	4.5	6.3	3.2	7.9	8.5	9.8	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.4	9.7	6.8	9.4	5.2	4.6	41.8	8.0	3.7	4.9	15.0	6.0	5.3	3.9	7.0	6.6	2.6	9.0	7.6	3.9	5.6	5.1	8.2	3.8	4.4	7.3	12.0	7.9	11.3	6.5	4.3	5.1	9.3	14.1	2.5	6.5	4.7	6.2	14.9	7.8	15.1	2.7	3.5	4.0	3.2	4.1	4.7	4.0	9.4	7.9	1.8	5.1	4.3	2.2	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1	0.0	7.7	5.2	22.9	4.6	17.8	32.7	28.1	13.4	4.5	26.2	23.6	37.5	162.5	21.0	2.6	11.2	33.1	23.3	14.0	23.8	11.3	45.7	1.1	16.0	11.6	12.7	22.0	11.1	9.4	1.0	13.3	7.6	11.8	44.1	16.4	8.5	13.9	23.7	10.6	92.2	32.2	12.9	7.5	9.4	11.7	3.6	30.4	13.1	23.0	22.0
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810022-24949459	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 113.0;Early spermatids: 140.5;Exocrine glandular cells: 118.7;Late spermatids: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 14.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;monocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.9;NTERA-2: 59.6;RH-30: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		85000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	12.5	6.1	5.2	6.9	5.7	2.6	6.3	1.3	7.8	4.3	3.0	2.6	0.0	1.4	8.6	3.9	2.9	7.8	4.7	2.4	4.7	7.9	1.8	1.8	13.8	7.4	11.3	2.9	8.3	52.7	1.1	19.1	14.0	18.5	2.0	3.1	12.3	4.4	1.4	1.3	1.2	3.8	5.9	6.3	2.4	2.4	7.3	2.0	7.1	1.7	0.7	5.3	4.3	6.3	1.1	5.4	1.0	14.7	0.0	0.2	0.8	6.0	2.4	22.5	0.0	6.5	12.7	11.6	12.4	8.3	7.0	11.8	13.6	17.1	22.5	0.0	20.6	1.3	2.4	16.0	0.1	18.8	51.9	3.1	18.3	0.4	7.3	23.5	20.7	6.7	16.4	0.4	17.8	3.7	15.2	23.7	11.7	17.6	0.2	5.9	0.1	13.0	5.8	59.6	0.0	1.6	0.0	65.0	0.3	0.0	2.1	0.0	12.3	0.0	0.0	0.1	25.2	0.0	8.9	31.0	4.2	15.7	16.7	11.6	2.7	2.7	31.4	14.8	12.5	0.0	0.0	2.1	0.0	0.0	3.4	0.1	1.1	0.0	0.1	5.4	0.0	0.0	0.0	1.0	0.0	14.7	3.3	0.2	0.8	5.2	5.7	1.3	7.4	4.7	7.9	11.3	2.9	18.5	2.0	14.9	21.3	0.8	0.1	7.7	113.0	1.9	2.5	0.0	1.2	0.0	2.0	45.4	1.7	1.4	140.5	9.0	0.0	0.0	118.7	16.8	13.4	0.3	11.5	0.0	64.2	39.7	0.0	9.8	81.1	235.6	6.6	40.9	6.8	26.2	0.0	5.2	79.2	0.0	3.9	0.0	9.2	6.5	1.4	1.7	1.1	6.4	18.8	0.7	0.0	0.1
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	11.8	34.1	6.7	10.9	7.7	3.8	15.0	15.0	10.7	11.9	16.7	11.3	15.8	10.2	12.9	9.8	24.6	11.9	15.2	25.1	6.8	6.9	22.6	8.0	19.9	16.3	9.8	7.8	22.3	42.6	9.0	12.3	27.5	22.0	16.8	12.1	6.3	24.7	17.2	23.3	9.8	10.3	17.5	7.6	10.9	22.8	15.9	10.7	12.5	19.1	23.3	16.7	29.2	12.2	15.0	18.2	1.8	9.8	8.8	15.4	7.1	17.5	21.1	5.6	11.9	23.4	7.9	10.0	7.8	4.0	9.6	9.4	21.2	10.8	20.7	8.9	6.9	3.0	8.3	8.6	13.6	4.8	12.8	21.9	7.6	9.5	1.4	22.7	10.2	7.1	11.5	8.7	7.1	10.3	9.4	13.3	16.0	9.6	12.7	3.5	21.0	13.9	10.8	4.9	27.9	10.3	21.2	9.7	22.8	9.1	72.7	30.3	8.6	11.8	19.5	5.7	4.1	12.4	5.0	7.4	9.4	9.0	11.0	9.7	12.0	15.9	9.9	5.1	16.0	6.1	0.0	8.7	1.8	9.7	9.8	13.6	15.0	11.7	12.4	16.1	12.8	10.8	9.6	0.4	8.8	3.7	18.2	15.4	7.1	6.7	7.7	15.0	10.7	6.8	6.9	9.8	7.8	22.0	10.7	26.8	34.4	9.0	26.7	5.4	8.2	22.1	20.4	6.7	13.6	12.2	19.6	54.6	61.3	34.2	5.8	13.5	15.6	0.0	18.6	15.8	11.7	16.4	23.1	8.3	23.4	1.6	19.1	12.3	4.7	6.2	16.1	8.6	23.6	33.3	25.8	5.6	19.8	14.0	28.3	28.2	11.2	19.4	16.1	7.0	17.1	6.1	38.3	7.0	30.3	40.4
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1, alpha polypeptide"	P12694	19	41397460-41425005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 13.3;Ductal cells: 12.3;monocytes: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 49.4"	"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA					"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	18.4	36.1	11.5	9.2	14.9	11.4	12.9	9.3	19.3	12.5	11.2	16.6	25.0	11.2	11.0	11.2	31.0	15.0	12.4	41.1	10.8	9.5	23.4	47.6	12.3	17.0	16.0	17.6	13.8	28.2	15.7	12.6	13.4	12.7	12.6	8.8	15.0	23.1	31.1	61.7	15.6	10.4	10.8	11.2	13.2	22.0	21.2	13.5	15.8	21.8	25.3	15.9	14.0	15.1	16.5	45.9	17.6	38.0	25.9	19.7	27.1	14.4	26.5	2.3	14.2	6.6	4.1	6.1	3.5	6.8	7.0	8.9	6.0	10.0	11.7	8.0	3.8	2.8	5.8	4.4	7.2	3.7	12.2	12.7	8.1	13.8	5.7	14.3	8.5	6.0	7.3	10.4	4.7	10.3	7.8	13.4	15.6	8.1	22.0	6.3	13.0	7.3	5.1	4.0	17.4	6.6	8.8	7.9	27.7	9.8	6.8	10.3	12.4	12.5	28.6	8.7	3.3	14.6	22.9	10.1	7.5	7.7	4.3	7.6	49.4	19.9	11.4	27.1	15.9	8.7	13.5	36.9	17.6	15.8	38.0	18.2	16.5	15.9	16.1	45.9	16.4	13.4	15.3	10.9	25.9	26.1	17.6	19.7	27.1	11.5	14.9	9.3	19.3	10.8	9.5	16.0	17.6	12.7	13.5	0.0	13.3	0.5	0.0	0.2	0.0	0.0	0.0	1.4	6.8	5.2	0.0	1.6	3.3	12.3	0.6	0.6	3.4	0.0	10.3	1.6	0.8	0.0	4.7	2.1	2.5	0.0	5.8	3.1	4.1	0.4	0.6	1.2	3.3	15.4	5.3	0.4	9.4	2.9	0.4	1.6	1.2	0.0	0.4	1.7	0.9	0.6	1.7	0.0	6.4	0.0
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 179.1;Proximal tubular cells: 617.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.3	10.7	10.9	9.5	2.4	1.2	13.4	10.0	6.8	6.3	8.1	2.0	6.6	11.8	17.4	6.2	3.1	24.0	9.4	10.1	2.3	27.0	19.9	17.7	6.5	3.4	22.7	1.4	27.8	6.1	7.8	2.4	2.1	20.1	25.0	6.3	41.3	5.0	3.5	12.5	11.0	5.8	7.0	11.4	5.2	5.1	12.2	7.0	3.7	4.4	2.4	6.5	6.5	11.0	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4	29.8	52.6	3.4	39.4	27.0	1.3	8.5	38.2	22.7	33.0	102.9	0.0	6.7	179.1	38.9	1.1	24.3	37.4	0.0	19.3	13.9	51.4	21.0	18.5	63.8	17.7	3.2	22.0	28.3	13.2	2.1	64.7	10.3	21.9	19.8	19.9	45.8	21.4	14.1	73.2	617.5	2.2	12.9	24.2	0.7	1.7	23.3	2.9	17.3	23.0	33.1
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		33000			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.9	15.0	13.8	8.8	13.7	6.2	14.7	18.1	18.7	10.5	12.3	14.0	14.2	12.8	10.8	21.4	11.9	10.0	8.6	17.3	13.8	14.7	27.6	48.1	7.7	10.3	15.9	18.0	13.9	13.4	12.7	27.1	8.5	16.6	12.6	14.6	13.6	13.3	17.1	15.8	15.7	11.8	12.4	16.7	10.6	10.9	14.4	13.6	9.7	16.1	10.6	11.5	12.0	10.1	11.6	7.0	9.0	7.3	8.3	10.3	3.1	6.0	4.6	14.2	8.9	12.4	14.8	2.9	4.4	6.0	5.3	4.9	5.4	6.5	12.5	2.4	3.3	5.0	6.6	13.1	13.9	5.8	4.7	6.5	21.9	10.8	7.2	7.5	8.6	7.8	9.6	12.1	3.8	6.5	12.7	15.6	10.6	11.8	10.1	8.4	3.1	8.9	14.1	5.1	4.2	7.0	7.8	5.0	5.3	18.7	6.4	12.6	9.5	5.3	7.6	11.3	12.4	8.2	5.6	9.2	5.6	3.0	6.2	4.4	10.1	6.7	6.0	9.7	10.6	3.4	8.6	6.1	9.0	10.3	5.3	6.2	8.5	7.1	10.0	5.2	11.6	8.0	10.2	4.6	8.3	7.3	7.0	5.9	3.1	13.8	13.7	18.1	18.7	13.8	14.7	15.9	18.0	16.6	13.6	0.0	6.5	22.4	28.5	20.5	34.4	26.0	28.1	10.7	9.1	47.1	37.3	35.3	43.1	51.8	12.8	15.2	25.9	46.7	36.9	21.5	17.7	26.4	2.3	66.8	22.0	58.8	28.2	18.4	25.1	19.4	41.1	19.0	33.7	21.6	21.3	37.5	33.5	28.5	29.4	68.1	45.4	58.2	15.1	50.2	34.3	17.7	16.9	25.5	23.4	19.4
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.8	33.9	26.2	32.1	18.4	13.3	22.5	18.1	16.9	22.5	23.0	29.0	55.6	28.1	21.0	21.0	34.9	18.4	15.8	23.8	6.8	21.3	19.1	25.4	38.3	37.0	30.7	22.8	36.3	22.9	18.3	19.1	11.1	21.9	16.8	32.1	28.8	48.3	12.4	37.8	73.3	71.9	31.0	18.7	32.8	51.9	15.8	36.6	14.4	29.2	49.3	30.9	17.3	18.7	23.9	16.5	40.9	35.2	21.4	37.7	21.3	21.6	38.7	35.2	33.5	32.5	29.8	35.6	29.5	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2	38.7	35.8	50.6	18.9	30.3	28.2	46.2	45.9	24.1	19.4	34.9	3.9	21.5	10.0	27.3	2.7	34.3	46.6	46.7	35.0	26.5	27.8	33.2	23.1	79.0	37.1	38.1	44.3	48.5	64.1	3.6	41.7	35.1	43.9	24.4	42.4	41.9	38.2	31.6	33.6	29.3	15.7	6.5	27.0	6.0	15.1	33.1	16.6	39.6	51.0	23.8
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.7	5.8	5.3	10.8	11.7	10.3	12.4	8.0	6.5	7.2	8.7	12.0	4.5	10.7	11.7	4.8	4.6	10.5	11.8	8.5	9.0	11.2	6.8	7.7	11.1	5.9	10.1	10.1	3.7	10.0	9.4	5.9	9.3	6.5	6.7	10.0	12.4	11.7	5.7	2.7	8.4	3.3	11.2	7.8	11.5	8.2	19.4	8.0	7.9	10.6	9.4	5.8	17.8	15.9	13.4	9.8	12.5	6.3	7.7	7.1	4.7	9.1	7.2	8.2	8.3	5.5	8.4	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2	20.8	28.4	16.7	5.9	6.1	21.3	62.5	20.4	16.0	9.1	12.2	37.3	16.0	43.1	8.1	0.6	6.7	8.1	0.0	7.2	10.3	7.5	7.4	2.3	43.1	7.4	14.3	8.7	10.4	7.5	0.9	14.1	7.8	3.3	6.4	12.5	15.6	6.7	3.5	19.8	26.5	20.8	6.5	8.1	2.4	5.5	6.4	6.9	10.0	12.7	4.6
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		No	No		8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.7	8.2	17.7	12.9	42.7	13.8	8.6	12.9	19.2	14.0	13.8	5.9	16.5	49.8	6.9	10.5	9.1	11.8	23.6	17.8	15.5	15.2	12.3	11.6	15.6	13.0	6.8	24.4	5.4	14.3	9.5	9.9	9.1	11.5	9.4	35.0	14.3	26.5	15.8	15.9	41.4	9.7	8.4	38.7	10.9	31.6	24.9	24.9	15.1	35.6	21.5	12.3	12.4	44.5	12.7	10.8	21.2	19.3	5.2	9.9	5.6	13.9	7.0	15.0	17.3	21.6	13.5	16.6	7.6	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2	26.8	26.0	29.0	45.8	13.9	7.3	194.2	61.1	81.7	36.4	33.2	3.9	27.5	135.9	37.9	159.1	14.3	244.0	46.7	28.1	33.2	15.5	29.6	10.4	229.1	96.2	6.4	31.2	19.0	32.4	78.4	42.8	17.2	20.3	6.4	71.1	24.6	30.7	84.2	33.2	241.4	5.7	38.8	30.8	25.1	20.1	15.8	14.2	16.2	172.2	38.7
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 460.9;Proximal tubular cells: 261.0;Syncytiotrophoblasts: 227.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced					NA	NA		780000			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	17.7	40.3	8.4	9.4	10.0	2.1	23.8	9.3	9.2	13.7	16.5	8.7	8.3	10.0	15.3	12.0	8.8	14.0	11.9	36.2	6.7	7.4	45.8	56.5	8.3	8.3	9.8	7.0	12.6	20.2	24.8	12.5	27.7	10.6	15.8	10.3	19.6	15.5	14.8	31.4	7.5	17.2	19.6	7.5	6.6	11.6	14.5	7.2	8.1	26.3	17.7	5.6	15.2	10.8	12.5	12.9	5.4	14.7	14.0	17.2	11.1	19.2	12.4	7.7	13.1	21.1	31.0	8.8	13.2	22.4	12.9	14.4	6.8	20.7	7.9	10.8	21.5	23.3	17.1	9.2	17.6	17.1	5.5	11.1	4.5	17.7	25.7	19.3	5.4	4.4	29.2	14.4	9.5	29.3	28.1	18.5	10.1	16.0	7.7	30.5	7.6	5.6	8.0	8.3	28.5	17.8	5.8	8.6	8.1	26.4	12.5	8.6	8.7	25.4	41.0	17.9	19.9	19.9	10.8	11.1	7.6	15.7	12.6	7.7	15.1	10.4	4.8	11.6	17.0	21.8	2.3	11.7	5.4	12.0	14.7	16.1	12.5	13.4	13.7	12.9	11.4	17.2	13.9	2.1	14.0	13.4	5.9	8.4	11.1	8.4	10.0	9.3	9.2	6.7	7.4	9.8	7.0	10.6	7.2	8.9	5.4	12.3	31.3	18.9	14.6	93.6	38.2	32.1	12.5	45.4	3.9	134.5	460.9	26.7	46.7	20.2	28.4	23.3	25.6	107.8	49.5	40.5	2.3	140.3	46.4	22.3	15.0	21.5	26.9	46.3	41.4	16.6	62.4	10.8	26.7	29.8	25.8	24.6	34.6	261.0	9.4	45.3	37.6	28.1	48.2	13.6	227.8	11.7	39.7	43.5
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.8	0.3	1.1	0.1	1.3	2.8	0.0	0.0	0.1	0.1	4.5	1.0	0.0	2.1	0.0	0.1	5.8	3.9	0.4	0.0	0.0	1.3	0.0	0.5	4.8	0.4	0.5	0.0	1.3	2.3	0.2	0.0	0.0	0.0	3.5	0.3	0.0	0.0	2.8	0.1	0.1	8.7	21.3	0.7	0.0	0.1	10.2	0.4	10.3	11.4	0.7	0.6	10.2	0.4	1.0	4.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3	0.0	0.3	0.0	8.0	1.3	0.0	0.5	33.1	0.0	1.2	181.5	0.0	0.8	38.1	1.7	0.1	0.0	273.5	0.0	2.7	0.7	3.1	15.6	9.2	1.3	1.3	0.0	25.8	1.3	0.0	0.0	23.6	0.0	1.7	0.0	229.5	0.0	0.8	137.2	6.3	14.6	0.0	12.9	0.4	0.2	1.0	3.0	95.8	0.0	114.3	5.7
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 343.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.3	38.3	18.7	34.7	18.4	8.1	28.3	13.9	13.9	37.1	24.4	39.3	19.3	38.2	12.7	15.9	24.1	23.5	60.2	28.1	20.4	30.2	33.8	18.0	54.9	32.5	30.9	33.9	28.2	17.3	26.7	28.7	16.1	8.1	27.1	34.4	25.7	30.3	17.2	78.9	30.0	51.0	51.8	30.3	49.5	30.7	34.6	67.6	28.5	24.8	33.1	43.6	40.0	47.9	25.3	24.9	50.4	31.6	12.1	15.9	25.3	33.1	21.0	24.8	34.5	47.2	22.1	71.4	23.4	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0	44.7	34.1	58.8	68.9	76.7	11.0	53.6	96.8	29.4	30.7	96.0	3.9	152.6	240.4	110.3	1.3	54.5	72.5	116.8	117.5	226.1	88.0	68.7	56.4	343.1	121.0	12.7	100.4	52.8	71.2	4.5	72.5	86.0	91.1	131.7	59.9	45.2	90.4	42.1	89.1	333.9	11.4	77.6	85.6	15.1	62.3	101.6	126.8	78.8	78.6	62.3
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell type enhanced"	"Detected in many"	19	"Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved					NA	NA					"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.0	6.0	1.0	7.1	1.1	0.1	1.1	8.3	0.5	0.5	5.5	0.1	3.7	6.2	0.2	23.0	0.0	0.6	0.0	0.6	0.2	0.4	1.6	0.1	0.8	21.7	0.0	9.7	8.4	0.2	0.6	0.2	16.3	7.8	2.1	0.0	24.6	0.0	0.2	0.5	0.2	0.5	3.5	4.1	3.3	0.0	0.7	0.0	17.6	1.6	4.1	0.0	0.8	4.6	2.6	0.2	0.2	0.0	0.1	2.3	0.2	0.0	4.2	7.8	0.2	5.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1	3.0	8.6	1.5	3.1	2.3	5.0	1.4	0.0	0.0	3.4	7.0	0.0	1.0	66.3	1.4	0.3	3.6	0.0	0.0	1.0	2.1	11.5	3.7	6.9	26.6	120.5	11.1	12.7	21.5	7.6	0.9	3.7	13.5	20.3	13.6	0.0	38.4	4.0	0.0	6.7	271.8	1.4	0.0	4.1	0.9	7.0	1.6	1.8	2.2	0.0	2.3
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 52.9;Hofbauer cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	7.0	8.1	0.8	4.1	2.9	10.7	0.5	8.8	14.0	1.7	3.6	0.6	12.3	0.4	2.9	10.8	0.3	2.1	0.8	1.3	0.9	31.6	1.9	0.5	6.4	23.1	2.7	0.1	35.9	5.1	2.2	8.4	1.7	4.1	0.8	0.4	1.6	0.3	6.6	15.1	0.2	5.0	0.6	3.0	1.1	0.8	2.8	7.8	5.4	0.4	3.0	1.5	1.1	5.8	0.8	0.4	11.2	0.5	4.1	3.7	1.0	34.9	0.9	0.6	5.1	0.4	14.3	0.9	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7	3.0	6.2	2.7	2.2	7.0	0.7	1.6	25.5	1.4	0.0	14.0	0.0	1.7	13.3	34.6	37.8	6.5	20.6	0.0	26.8	2.6	9.0	2.5	9.2	52.9	55.1	1.6	7.5	6.7	7.9	1.1	6.1	14.8	13.5	21.6	7.2	1.9	19.4	11.2	4.9	33.2	0.4	12.9	9.0	0.6	1.1	11.0	1.1	1.0	15.7	2.4
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.1	38.5	0.8	0.0	11.8	9.0	8.6	10.1	10.0	7.8	9.4	22.2	20.4	5.3	20.8	12.6	30.4	32.6	0.0	6.1	7.6	60.3	4.7	6.5	38.0	0.0	28.5	2.4	31.1	12.9	43.5	6.3	9.9	0.0	22.3	0.0	16.0	7.0	14.5	21.7	0.0	1.5	12.5	40.7	19.2	4.9	0.0	19.0	10.6	12.9	10.5	0.1	32.8	13.0	15.4	4.2	27.2	12.2	27.1	5.6	12.3	11.3	0.2	7.5	9.2	0.1	0.0	16.5	24.1	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6	23.8	8.1	24.1	49.8	32.3	0.3	9.7	117.2	8.1	10.3	45.4	0.0	50.0	26.6	84.2	36.1	22.9	185.2	0.0	63.6	102.1	14.2	53.7	23.0	69.2	75.1	3.2	23.2	28.8	55.0	45.4	18.4	40.5	42.2	143.3	93.7	9.4	88.6	161.4	8.9	60.3	1.7	12.9	29.5	27.3	17.2	36.8	51.5	35.8	83.1	52.5
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"liver: 9.7;placenta: 21.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;U-266/70: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA054911			Approved	Cytosol		NA	NA			Cytosol		"HPA054911: "	"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.7	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		66000	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.7	17.4	15.4	13.5	0.4	13.5	13.2	17.3	10.8	19.8	7.6	0.3	25.8	17.0	14.9	10.3	18.4	19.9	10.7	12.6	14.8	22.7	15.4	19.0	27.1	9.2	22.6	20.6	6.9	9.6	20.2	20.0	17.1	24.4	1.0	1.1	15.5	13.8	11.4	14.3	8.2	0.5	16.9	16.7	13.3	10.4	20.5	23.7	16.6	9.2	18.6	40.5	8.2	9.4	34.9	40.7	14.5	14.4	9.4	10.1	10.8	21.8	14.9	0.3	13.5	9.2	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7	26.8	46.2	14.3	16.6	2.1	24.6	72.6	45.9	42.8	40.9	41.8	13.7	16.5	81.2	15.9	4.4	18.0	17.7	23.3	13.0	4.8	15.4	16.0	32.5	123.8	25.1	15.9	18.9	17.2	20.2	4.9	19.0	13.9	5.0	31.5	22.5	25.1	14.1	3.5	23.3	60.9	18.9	19.4	13.9	19.0	4.3	0.5	8.2	12.2	33.1	11.2
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HL-60: 15.6"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.9	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.7	1.0	0.6	0.9	0.5	0.0	15.6	0.7	0.1	0.3	0.0	0.2	0.2	0.0	1.0	0.4	1.2	0.1	0.3	0.4	1.1	0.4	0.2	0.7	0.8	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.5	0.4	2.2	0.8	0.6	0.2	1.0	0.3	2.7	0.6	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.6	0.0	0.0	4.6	3.6	0.0	0.2	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		780000000	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.6	87.5	77.0	50.6	55.2	61.5	89.5	45.6	45.6	63.8	63.2	138.5	0.1	115.5	29.9	30.7	62.2	16.4	105.9	84.5	81.3	29.6	73.7	118.8	83.7	0.1	52.8	110.9	51.4	70.3	30.3	55.9	76.1	75.5	72.7	83.7	64.9	17.4	70.1	0.1	94.2	134.3	222.1	53.5	38.0	85.1	107.5	93.1	316.6	145.6	24.8	57.4	20.9	32.5	78.6	213.4	0.2	87.0	28.3	43.0	56.4	30.5	85.8	15.4	20.8	151.7	47.6	53.2	51.0	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6	131.0	259.8	264.1	356.5	64.9	144.4	2212.6	252.3	329.2	235.4	450.1	64.8	1548.4	2801.9	8.8	8.2	201.1	10.6	163.5	278.5	675.2	313.9	183.2	261.1	6.8	514.5	133.5	88.8	124.0	155.9	19.6	254.3	185.3	170.4	154.1	114.8	173.5	149.2	14.4	390.3	2766.7	85.3	232.8	418.6	17.7	95.7	56.1	1371.1	274.1	316.8	307.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412307-18452058	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 143.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 838.5;Spermatocytes: 827.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.1	0.7	0.0	0.9	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	143.9	0.3	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.7	3.6	1.1	0.2	3.8	1.2	0.0	0.0	0.3	2.0	1.5	1.6	2.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.2	2.8	0.2	1.1	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.2	1.0	0.2	0.1	0.6	0.0	0.4	0.2	0.5	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.9	0.0	2.2	3.5	0.5	0.1	0.2	0.1	0.9	0.4	2.8	8.7	0.1	7.8	6.8	0.3	0.1	0.0	0.1	1.3	0.7	1.0	0.6	1.0	2.3	0.8	1.8	2.2	0.0	2.4	3.8	2.6	3.6	0.2	1.1	2.7	1.7	1.2	0.7	0.9	0.6	0.4	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	3.3	0.3	838.5	0.6	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.0	78.1	21.6	0.0	0.0	0.0	0.0	1.0	1.2	0.0	17.0	2.9	0.6	19.4	0.0	827.5	26.0	0.5	0.0	0.0	0.0	0.1
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.2	5.4	3.4	3.6	15.1	6.9	7.0	6.6	9.2	7.2	8.2	7.5	5.7	15.8	10.7	5.8	12.6	7.4	5.2	4.3	9.3	5.3	5.8	13.4	6.2	7.9	10.0	8.9	7.7	7.8	5.0	3.4	7.8	4.9	9.7	13.9	7.4	8.3	8.1	11.7	8.7	4.5	3.9	22.4	6.0	7.2	7.8	20.2	10.6	22.7	7.7	5.6	25.2	34.7	7.1	3.7	53.1	12.7	4.7	5.6	4.5	4.4	9.7	8.5	15.5	16.0	6.1	12.9	5.2	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4	8.9	42.2	11.0	15.2	6.3	10.8	27.0	33.1	25.4	13.6	26.2	9.8	24.8	28.2	16.0	4.4	5.2	9.2	0.0	14.9	3.5	6.7	11.8	7.0	30.1	14.2	7.9	5.8	5.5	9.7	4.1	8.1	11.7	6.8	10.0	11.7	12.1	18.1	19.5	9.9	36.0	11.4	6.5	8.1	6.4	3.2	5.1	23.7	10.1	22.9	19.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.9	16.5	7.1	27.1	7.6	7.8	12.1	5.7	9.6	11.8	8.5	28.9	15.2	27.7	21.0	8.3	9.2	9.9	12.3	19.0	14.8	14.7	15.7	15.0	8.5	31.7	13.3	7.4	14.3	10.0	10.0	10.8	8.6	5.3	10.3	8.0	18.9	10.4	8.1	32.6	0.1	13.6	9.3	10.5	9.3	14.5	20.4	40.7	30.6	21.6	11.2	12.4	24.9	36.9	12.1	3.5	30.6	18.9	7.5	4.8	7.5	8.7	15.3	7.5	13.8	17.2	7.9	20.7	11.9	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9	14.9	23.4	22.9	14.2	11.7	12.8	60.9	17.8	16.0	18.2	15.7	5.9	40.3	18.3	18.3	3.1	14.2	19.6	0.0	16.1	19.0	8.9	25.3	12.7	79.8	15.6	3.2	28.4	8.0	10.8	7.4	12.7	12.2	11.8	19.0	22.7	19.0	14.2	17.5	19.1	48.4	11.4	6.5	9.1	3.9	13.3	12.0	53.2	12.9	28.8	18.5
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 76.7;Distal tubular cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.4	3.1	5.7	4.1	19.4	26.4	16.5	9.9	12.6	5.0	7.6	7.7	8.0	9.9	3.0	9.7	3.8	6.7	6.9	5.1	5.3	9.2	6.0	6.8	8.7	22.1	10.9	7.6	5.6	17.5	7.5	3.4	6.7	11.2	5.7	7.9	8.9	17.4	4.8	8.2	5.6	8.9	5.2	17.7	7.7	6.7	6.5	18.4	7.7	5.2	6.5	4.7	3.7	21.9	9.7	6.9	17.3	7.3	7.4	5.9	4.6	6.0	3.9	16.7	6.8	10.5	9.6	12.4	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4	23.8	8.3	13.7	11.3	7.6	2.6	76.7	22.9	17.4	9.1	5.2	2.0	30.6	77.9	10.4	0.8	9.0	14.7	0.0	16.1	27.7	21.1	8.8	0.0	60.2	13.5	4.8	8.6	9.8	11.6	0.9	27.0	11.2	13.5	3.6	28.7	6.7	10.6	10.5	16.6	64.3	8.7	25.8	10.8	2.4	4.1	18.2	9.5	12.9	25.1	9.2
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.2;SCLC-21H: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA					"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.4	1.8	4.9	0.4	2.3	0.7	0.0	0.9	1.0	0.7	0.2	1.6	1.1	1.1	0.2	2.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.5	0.1	0.3	1.1	1.4	2.3	0.1	1.4	0.7	2.9	1.5	0.6	3.2	0.3	2.9	3.1	1.8	0.1	7.2	0.3	6.9	1.5	2.2	1.1	0.6	1.1	2.2	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8	6.0	1.0	0.0	1.2	0.7	3.0	1.2	2.5	121.8	6.8	0.0	0.0	0.1	11.6	0.7	123.3	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	3.2	1.2	0.0	0.0	17.1	1.7	0.2	1.7	0.0	0.0	7.7	0.1	0.0	2.8	5.1	9.9	0.0	1.0	50.4	4.0	0.3	0.0	0.0	0.0	0.4
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899126-83927026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 39.1"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 72.8;Cone photoreceptor cells: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA031625	Enhanced					NA	NA					"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favorable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	6.6	10.1	3.3	3.7	4.2	2.3	4.6	2.4	5.4	4.1	6.9	6.3	6.2	4.6	4.4	4.4	5.1	4.9	7.0	39.1	3.7	3.3	6.7	17.4	4.1	3.6	6.9	3.1	6.2	21.5	6.9	5.1	3.1	4.6	5.6	4.4	8.0	6.4	4.1	31.0	4.0	5.1	5.8	3.3	3.8	6.7	7.1	5.7	3.3	5.6	5.7	4.6	6.4	5.4	0.7	0.7	2.3	0.8	0.1	0.9	0.2	0.5	2.3	1.6	2.7	5.0	2.4	3.7	1.2	1.8	1.1	0.5	2.3	1.7	0.4	2.8	2.1	2.1	2.5	2.8	0.8	1.0	1.9	2.1	1.7	0.9	1.4	2.8	1.5	3.2	3.0	2.8	0.7	1.1	1.9	1.2	2.3	2.1	0.8	1.3	4.4	1.5	4.5	2.0	2.2	1.0	3.5	1.4	2.2	3.0	2.7	2.5	2.3	4.5	0.7	2.1	2.5	4.3	1.9	1.6	1.8	0.4	1.4	0.5	2.7	2.6	3.2	1.8	2.1	1.9	0.8	0.7	2.3	0.5	0.5	0.3	0.7	0.8	0.7	0.7	0.3	0.8	0.9	0.3	0.1	0.8	0.3	0.0	0.2	3.3	4.2	2.4	5.4	3.7	3.3	6.9	3.1	4.6	5.7	6.0	5.3	15.6	6.1	1.8	25.1	72.8	20.4	0.0	7.9	22.7	117.8	16.1	26.6	5.6	3.6	6.7	14.8	0.0	4.7	8.7	5.6	8.5	5.7	35.5	10.9	15.9	9.8	9.2	5.6	4.7	13.6	6.9	3.3	1.8	15.8	17.7	5.9	10.5	18.4	18.0	48.9	6.5	7.2	10.5	12.4	1.8	6.9	9.2	16.6	6.8
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.4	4.8	14.5	16.9	28.9	27.5	8.0	12.1	16.0	12.8	19.0	5.5	7.0	12.5	9.7	12.9	19.4	7.7	16.1	8.6	18.1	10.6	11.7	6.6	11.0	14.4	21.1	8.5	6.4	16.6	12.8	13.0	15.2	11.5	12.3	13.6	12.0	15.0	15.0	8.4	9.9	8.4	6.2	14.2	3.5	8.9	18.2	17.2	14.8	12.9	13.5	9.4	13.3	9.6	20.0	15.9	8.3	13.6	8.8	11.9	8.8	16.1	16.3	5.9	6.7	10.7	16.8	10.0	10.4	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9	17.9	17.4	10.4	16.2	17.7	16.5	60.2	22.9	18.7	21.6	31.4	2.0	21.2	24.9	14.4	5.7	10.0	27.4	0.0	12.8	11.2	13.8	13.3	10.4	117.7	10.8	19.1	50.0	14.1	10.0	2.1	22.2	9.4	8.5	2.8	23.1	28.2	10.5	23.0	26.2	34.2	15.2	32.3	12.2	18.6	14.3	17.6	27.9	7.9	21.2	11.5
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 84.6;Proximal tubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		120000	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.3	5.9	9.8	3.2	9.4	8.2	5.5	3.3	5.0	3.1	2.9	7.3	4.5	0.2	5.1	3.2	4.0	3.8	2.9	4.6	5.1	5.5	3.2	7.7	4.2	15.8	5.2	0.3	3.7	7.5	5.0	2.9	4.8	7.6	6.4	4.2	3.0	4.4	5.6	3.6	0.8	17.3	6.1	11.8	2.6	6.7	4.2	5.4	54.3	6.6	30.1	3.6	2.2	12.6	5.5	11.1	9.1	13.7	4.6	3.2	2.7	2.2	2.3	4.3	3.9	0.1	6.1	41.9	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9	3.0	8.3	7.3	25.7	1.6	15.4	8.7	38.2	10.7	10.3	19.2	27.5	21.2	84.6	13.8	14.8	9.9	14.0	0.0	7.3	5.4	7.1	14.3	13.9	41.9	10.3	27.0	3.5	11.6	10.2	7.9	8.1	7.2	5.0	2.8	10.1	10.4	6.2	14.0	12.7	63.9	32.3	12.9	8.9	4.8	4.3	3.3	25.3	4.9	26.5	19.5
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 317.0;Late spermatids: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	19.8	14.2	13.7	20.5	10.4	11.5	24.2	10.5	11.4	16.0	22.6	21.1	14.1	24.8	29.3	14.8	14.3	11.1	16.0	14.1	24.3	14.8	13.6	43.5	16.8	31.8	22.2	33.4	19.4	13.6	13.5	10.1	23.1	10.3	17.9	41.8	31.6	13.3	12.2	37.9	33.0	19.6	11.5	30.5	12.9	9.2	11.3	35.5	29.3	21.8	27.3	20.3	26.5	15.8	24.1	12.9	31.3	19.9	13.4	8.0	8.6	22.4	9.2	25.4	21.0	20.7	11.4	13.0	9.3	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5	8.9	9.4	10.0	7.3	3.7	15.1	45.4	12.7	18.7	11.4	19.2	9.8	51.9	33.2	19.9	317.0	6.0	14.4	23.3	12.5	19.8	10.3	9.0	28.8	63.8	31.1	11.1	8.7	8.6	13.1	128.9	12.7	15.4	18.6	24.4	12.7	10.3	14.9	14.8	10.3	71.0	13.1	12.9	8.3	10.9	28.8	2.9	42.6	9.6	21.7	8.9
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 193.7;Muller glia cells: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.2	12.2	1.3	5.6	46.8	3.4	12.4	33.5	5.4	1.3	2.2	29.9	12.1	2.9	4.4	18.7	2.0	11.1	6.1	4.8	2.7	33.6	15.4	5.2	12.0	9.2	1.8	2.4	5.7	2.0	6.2	5.2	4.9	5.9	4.9	2.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	25.8	6.0	2.2	1.4	1.7	9.1	6.0	0.8	1.0	2.8	20.9	1.7	1.8	4.1	1.3	7.4	2.0	3.4	9.2	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1	11.9	28.0	0.0	8.6	11.9	3.0	8.1	30.6	20.1	18.2	193.7	21.6	15.7	3.3	12.8	53.9	10.3	25.7	0.0	15.2	16.8	18.4	19.0	2.3	35.0	16.7	3.2	4.1	1.8	4.0	5.2	2.6	6.0	16.9	0.0	13.1	296.7	39.0	25.9	3.5	18.6	10.4	0.0	8.2	9.3	5.3	12.2	35.1	2.2	14.1	16.0
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)"	Q96NR8	14	67701886-67734452	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.3"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 371.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.7;K-562: 1.9;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.0	1.9	0.0	0.0	0.5	0.0	1.2	0.3	0.5	4.9	0.0			0.0	0.0	5.3	9.9	0.1	10.6	0.0	0.1	0.3	7.7	1.9	0.0	0.0	1.3		0.0	1.7	0.0	0.1	0.0		0.0	0.0		0.6	0.0	0.0	29.3	0.0	0.0	0.0	0.0	6.9	0.0			0.4		0.6	0.0	9.7	0.2	0.6	0.0	0.9	0.5	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	1.5	0.0	2.7	0.7	0.2	0.6	0.0	0.0	0.6	0.4	0.0	0.9	0.1	0.0	0.2	0.0	1.0	0.1	0.2	0.0	0.7	0.2	1.9	0.7	0.1	0.7	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.3	1.2	0.0	0.0	1.0	2.3	0.1	0.7	0.1	0.0	0.3	1.3	0.4	0.0	1.6	0.7	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.6	0.1											0.0	0.0	0.0	0.2	4.1	37.5	0.0	20.4	0.0	0.0	1.8	137.4	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.6	0.0	0.9	0.4	0.0	4.2	0.2	19.1	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	29.8	1.0	0.2	0.0	6.5	371.5	0.0	0.1	0.0	0.0	33.8	0.0	0.0	0.0	0.3
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	0.4	3.2	3.8	2.3	0.2	1.6	10.1	2.0	4.7	3.7	0.9	4.8	1.4	1.3	0.9	1.9	1.4	0.7	2.8	1.6	4.0	1.0	0.7	5.2	0.8	3.1	0.8	6.9	4.7	2.5	1.0	10.0	1.3	5.5	2.2	2.7	2.8	8.0	3.6	0.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0	14.9	16.2	5.1	19.9	9.5	17.3	22.2	28.1	6.7	11.4	14.0	39.3	30.2	10.0	12.3	18.5	6.5	27.1	0.0	5.7	26.9	6.0	23.1	8.1	6.0	9.9	23.8	11.5	16.5	4.1	11.2	3.4	5.0	6.8	1.8	19.8	10.0	11.4	26.2	3.2	3.4	27.0	6.5	5.1	1.4	9.6	15.3	175.4	8.7	21.9	72.9
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.6	5.9	5.0	4.1	15.1	16.1	16.8	11.4	11.7	10.3	10.3	4.6	9.7	18.4	6.8	6.8	13.4	10.2	7.2	13.3	12.1	10.2	19.8	7.2	6.5	13.8	12.9	8.7	9.8	12.2	13.6	10.0	15.7	14.5	9.5	7.5	12.8	6.3	16.9	6.0	7.5	15.4	13.5	14.3	16.9	11.0	13.6	7.9	20.2	12.2	7.7	13.4	6.2	13.7	16.2	10.9	6.8	5.0	9.5	14.7	9.1	11.6	13.5	17.9	14.7	13.7	10.5	6.0	11.5	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8	14.9	10.9	21.4	26.0	21.8	22.4	43.0	22.9	2.7	6.8	15.7	5.9	40.0	26.6	32.8	16.1	17.9	14.0	0.0	30.8	42.8	33.7	31.0	12.7	26.8	21.0	14.3	12.7	17.2	15.1	9.4	61.9	14.8	21.9	22.6	27.1	25.0	23.9	32.3	42.1	30.5	18.0	32.3	30.7	71.9	28.2	16.3	38.2	17.5	29.8	23.7
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced					NA	NA					"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	9.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	21.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2	44.7	125.1	0.0	5.5	45.3	0.2	0.1	10.2	48.2	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.0	1.2	0.0	1.5	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.3	1.0	7.1	9.9	58.7	3.2	0.0	0.0	1.4	0.0	0.3	0.2	4.1	63.1	0.0	0.0	4.5	19.5
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011488	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.5;hTCEpi: 10.8;MCF7: 7.1;RT4: 17.4;SCLC-21H: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain					NA	NA					"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	1.3	0.3	0.2	6.5	0.5	0.3	5.8	0.2	0.2	3.5	12.2	0.0	4.1	7.9	4.6	3.9	11.5	2.1	2.6	2.2	0.2	0.4	7.4	8.3	4.1	3.6	0.2	0.1	0.6	14.3	3.8	14.9	0.3	0.2	3.1	2.2	1.4	18.8	3.4	0.7	16.7	21.3	1.5	0.3	3.8	3.6	7.3	0.1	8.2	6.1	7.3	13.7	4.3	4.7	4.0	0.4	0.8	0.0	3.6	4.6	2.0	3.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	0.0	1.5	0.0	0.3	7.5	0.0	5.8	0.0	0.0	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.3	10.8	1.4	5.5	0.0	0.0	0.0	1.2	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.3	17.4	7.5	0.0	0.2	3.6	0.0	0.2	0.1	0.0	0.2	0.0	4.0	0.0	0.0	3.7	5.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	1.8	0.0	2.4	4.0	1.5	2.5	0.3	2.1	4.6	3.6	0.1	3.6	0.0	0.4	3.0	2.0	0.2	0.5	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.6	1.7	3.5	5.3	0.0	2.4	2.5	4.0	2.3	1.8	0.0	0.4	3.3	8.0	0.9	0.3	3.1	0.0	6.5	0.1	0.5	3.2	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.7	0.0	4.9	0.0	4.9	3.5	0.0	2.1	0.0	0.0	0.3	8.2	3.4	8.0	0.2	1.0	3.3	4.1
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 22.2;Erythroid cells: 23.3;Muller glia cells: 18.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2											0.0	3.7	11.9	0.2	0.7	7.7	1.6	5.1	2.7	0.0	0.0	0.0	0.7	0.0	0.6	1.6	2.1	22.2	23.3	0.4	0.2	1.1	0.9	2.3	3.2	2.1	4.8	2.4	3.7	11.0	1.1	5.5	3.1	1.7	8.2	9.0	18.4	0.2	3.5	1.4	0.2	3.6	0.0	1.0	0.6	0.1	1.5	1.1	8.6	4.7	0.3
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923154-56934405	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 31.4;tongue: 27.8"	"Cell type enhanced"	"Detected in single"	38	"Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 1.1;SK-BR-3: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.1	9.6	0.1	0.1	0.1	0.0	0.7	0.1	8.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.1	2.0	0.1	0.5	31.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	0.1	27.8	9.9	0.1	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 178.4;Late spermatids: 342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HSkMC: 16.2;TIME: 15.2"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA					"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.2	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.7	2.2	1.6	0.7	1.1	1.9	2.3	1.6	2.5	15.2	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	11.5	6.9	2.9	2.8	4.5	1.6	5.0	1.4	4.6	1.7	0.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	2.9	0.8	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7	3.0	21.9	3.0	19.5	15.9	9.2	3.0	0.0	5.3	9.1	7.0	5.9	1.6	1.7	3.0	178.4	13.0	1.0	0.0	2.8	59.8	10.3	5.3	33.5	3.0	13.8	7.9	13.8	16.5	57.3	342.9	13.0	14.6	8.5	1.8	1.9	3.8	5.2	14.4	6.7	2.1	6.0	6.5	4.6	2.8	9.6	18.6	7.2	8.7	1.6	9.6
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099413-79212667	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	13.2	7.4	19.2	10.5	17.9	5.3	11.9	21.5	14.6	8.9	5.9	20.5	14.8	8.9	12.6	17.1	11.6	13.4	10.0	6.1	17.0	17.7	19.2	17.8	7.1	6.5	19.7	12.5	9.4	10.5	22.3	11.5	7.6	16.1	10.9	5.3	11.4	10.6	15.4	4.9	9.6	7.2	11.9	20.9	5.4	7.6	15.8	17.9	10.3	29.4	4.9	8.9	8.7	8.6	8.5	13.8	5.4	8.8	7.8	12.3	5.4	5.0	4.5	5.0	3.2	5.3	2.4	5.3	0.7	1.5	1.7	1.5	3.5	4.3	9.5	3.8	0.7	2.4	4.4	2.5	0.6	1.3	5.0	12.8	3.1	0.8	7.2	4.0	7.8	1.5	2.9	1.8	1.1	1.0	0.4	2.2	13.4	4.2	1.9	1.2	40.0	13.4	10.6	4.3	3.1	2.6	14.2	1.9	9.6	2.4	1.7	8.1	5.2	3.1	5.8	1.7	5.0	5.7	5.4	0.5	1.3	4.5	1.0	2.9	0.0	8.9	19.4	5.1	4.0	2.2	5.4	8.8	1.9	10.5	7.2	12.3	8.5	8.5	9.2	6.8	6.4	8.4	8.9	0.8	7.8	5.0	13.8	12.3	5.4	19.2	17.9	21.5	14.2	17.0	17.7	19.7	12.5	16.1	17.9	6.0	5.8	8.5	14.2	8.1	6.9	6.9	17.8	24.1	17.0	14.0	3.9	21.1	28.2	10.9	34.6	9.0	5.1	0.0	9.1	10.9	9.9	12.1	12.7	16.6	7.7	4.8	9.2	8.6	5.4	34.4	13.0	6.5	5.0	2.8	4.5	36.6	4.6	5.8	16.6	15.7	11.6	6.5	8.3	14.4	12.4	5.9	14.5	6.4	6.3	11.1
